News

– New Module Expands Molecular Testing Capabilities, Increases Productivity and Flexibility for the Laboratory –

-- Revenue of $789.3 Million Grows 10.3%, 8.3% in Constant Currency --

NovaSure patients in study also used fewer pads and tampons, reported better menstrual-related quality of life and alleviation of PMS symptoms as compared to Minerva patients

--Presentations reinforce company’s women’s health expertise, focus on scientific data--

Latest Breast Cancer Screening Improvements Launched as Company Marks Installation of More Than 5,000 3D Mammography™ Systems Throughout the United States

In partnership with Hologic, the TV personality uses personal story to encourage women to get tested for cervical cancer

Partnership will allow hospitals easier access to integrated suites of diagnostic imaging modalities, advanced informatics and services for comprehensive breast screening and diagnosis

--New product scheduled for global commercial availability in April 2018--

--Partnership leverages Hologic DXA systems to provide sports science market with first sport- and position-specific scores correlating body composition to performance--

-- Revenue of $791.1 Million Grows 7.7%, 6.7% in Constant Currency --

--Aptima assay portfolio rapidly expanding with the addition of tests to quantitate HIV-1, HCV and HBV now available on the fully automated Panther system--

---New Innovation Enriches Mini C-Arm Technology with Diversified Imaging Options, Upgraded Storage and Transport, and Enhanced Interface---

--Superior Radiofrequency Treatment Minimizes Fine Facial Lines and Wrinkles, Tightens Skin Through Soft Tissue Coagulation, and Improves the Appearance of Cellulite--

- Proceeds Expected to Contribute to Retirement of All Outstanding 5.25% Senior Notes due 2022 -